SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B2 - Prospectus [Rule 424(b)(2)]:
SEC Accession No. 0001193125-15-356389
Filing Date
2015-10-28
Accepted
2015-10-28 16:50:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B2 d190486d424b2.htm 424B2 512039
2 GRAPHIC g190486g61r59.jpg GRAPHIC 48366
  Complete submission text file 0001193125-15-356389.txt   579889
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 424B2 | Act: 33 | File No.: 333-200452 | Film No.: 151180784
SIC: 2834 Pharmaceutical Preparations